Annie Neild
Consigliere Generale presso FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Provenienza dei contatti di primo grado di Annie Neild
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.
1
| Subsidiary | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Annie Neild tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Corporate Officer/Principal | |
| GENELUX CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Sonogene LLC | Director/Board Member | ||
| Nyenrode Business Universiteit | College/University | Graduate Degree Undergraduate Degree | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| MATINAS BIOPHARMA HOLDINGS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ENGILITY HOLDINGS INC | Aerospace & Defense | Director/Board Member | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree Undergraduate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Analyst Private Equity Investor | |
CircleUp Advisors LLC
 CircleUp Advisors LLC Investment ManagersFinance CircleUp Advisors LLC (CircleUp Advisors) is a venture capital subsidiary of Brightflow AI. Inc founded in 2011 by Ryan Caldbeck and Rory Eakin. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member | |
| Knoll Pharmaceutical Co. | Corporate Officer/Principal | ||
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Total Administrative Services Corp.
 Total Administrative Services Corp. Miscellaneous Commercial ServicesCommercial Services Total Administrative Services Corp. provides administrative solutions and employee benefits solutions. The firm is an administrator of health and other benefits accounts, compliance, and payroll services. Its products include ACA employes reporting, agriplanNOW, FlexSystem, COBRAToday, DirectPay, FMLAMatters, Medicare Part D. The company also offers flexible spending accounts, health reimbursement arrangements, funded HRAs, health savings accounts, workplace giving, tuition reimbursement, payroll, COBRA, FMLA and retiree continuation services and compliance services, includes ERISA, PCORI, form 5500 preparation and non-discrimination testing. Total Administrative Services was founded in 1975 and is headquartered in Madison, WI. | Miscellaneous Commercial Services | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Undergraduate Degree | |
| Rutgers Business School | College/University | Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Santander US Capital Markets LLC
 Santander US Capital Markets LLC Investment Banks/BrokersFinance Santander US Capital Markets LLC provides brokerage services. The company is based in New York, NY and has subsidiaries in the United States. The CEO of the company is Joe N. Walsh. | Investment Banks/Brokers | Director/Board Member | |
| Shionogi USA Holdings, Inc. | Corporate Officer/Principal | ||
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Inositec AG develops small molecules as alternatives to antibiotics. It also develops a non-antibiotic small molecule that neutralizes the toxins secreted by clostridium toxins. The company was founded by Mattias Ivarsson, Bastien Castagner and Jean-Christophe Leroux in December 2015 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Chicago Department of Medicine | College/University | Corporate Officer/Principal | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Director/Board Member | |
General Atlantic Service Co. LP
 General Atlantic Service Co. LP Financial ConglomeratesFinance General Atlantic Service Co. LP engages in provision of investment services. It specializes in consumer, financial services, healthcare, and technology sectors. The company was founded by Chuck Feeney in 1980 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal | |
Adams Memorial Foundation, Inc.
 Adams Memorial Foundation, Inc. Services to the Health IndustryHealth Services Adams Memorial Foundation, Inc. provides individual and family services. The private company is based in Chantilly. | Services to the Health Industry | Director/Board Member | |
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Founder Corporate Officer/Principal Director/Board Member | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Founder | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 36 |
| Paesi Bassi | 7 |
| Regno Unito | 3 |
| Germania | 2 |
| Italia | 2 |
Settori
| Health Technology | 19 |
| Consumer Services | 12 |
| Finance | 9 |
| Commercial Services | 6 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 144 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 34 |
| Director of Finance/CFO | 18 |
| Chairman | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| James Topper | 52 |
| Louis Lange | 35 |
| Michael Davidson | 27 |
| David Topper | 25 |
| John Smither | 20 |
| Sander Slootweg | 18 |
| James Jacobson | 16 |
| William Jones | 14 |
| Douglas Kling | 12 |
| Will Lewis | 12 |
| Juliette Audet | 11 |
| John Kastelein | 11 |
| Mayur Ian Somaiya | 11 |
| Lina Gugucheva | 9 |
| Nicholas Downing | 8 |
- Borsa valori
- Insiders
- Annie Neild
- Connessioni Società
